Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release May 03 2022

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-03-2022-3

Aurobindo Pharma Limited has informed the Exchange about press release dated 03-May-2022 titled Press Release on USFDA approval for Bortezomib for Injection received by Eugia Pharma

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases